Notice for nitric oxide (Ikaria Australia Pty Ltd)
Active ingredients
nitric oxide
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
gas for inhalation
Indication
For the treatment of Acute Respiratory Distress Syndrome (ARDS) in ventilated patients in intensive care units (ICU)
Therapeutic area
Respiratory